一种肿瘤特异性突变,广泛表达于多形性胶质母细胞瘤 (GBM) 和其他肿瘤中,其表达增强了肿瘤发生率。
编号:200702
CAS号:129112-17-0
单字母:H2N-LEEKKGNYVVTDHC-OH
EGFRvIII peptide (PEPvIII) 是一种肿瘤特异性突变,广泛表达于多形性胶质母细胞瘤 (GBM) 和其他肿瘤中,其表达增强了肿瘤发生率。EGFRvIII peptide (PEPvIII) 是抗肿瘤免疫的一个真正的特异性靶点。
EGFRvIII peptide (PEPvIII) is a tumor-specific mutation that is widely expressed in glioblastoma multiforme (GBM) and other neoplasms and its expression enhances tumorigenicity. EGFRvIII peptide represents a truly tumor-specific target for antitumor immunotherapy[1].
DOI | 名称 | |
---|---|---|
10.1016/j.jim.2008.08.004 | Detection of humoral response in patients with glioblastoma receiving EGFRvIII-KLH vaccines | 下载 |